A randomized controlled trial for low-dose continuous Infusion of human atrial natriuretic peptide for high risk patients undergoing cardiac surgery
Phase 3
- Conditions
- myocardial infarction, angina
- Registration Number
- JPRN-UMIN000004537
- Lead Sponsor
- ihon University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
OPCAB Combined surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method major adverse cardiovascular and cerebrovascular events (MACCE)
- Secondary Outcome Measures
Name Time Method 1) postoperative death (early, late) 2) MACCE + hemodialysis (HD) 3) serum creatinine (sCr) and brain natriuretic peptide (BNP) levels at 1 week and 1 year postoperatively.